EHS
EHS

New treatment for adults with rare, life-threatening blood disease receives FDA approval



The U.S. Food and Drug Administration today approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease.

Source link

EHS
Back to top button